**
The World Health Organization (WHO) has escalated the public health risk associated with the ongoing Ebola outbreak in the Democratic Republic of Congo (DR Congo) from “high” to “very high.” This decision comes as the nation grapples with nearly 750 suspected cases and a troubling death toll that has reached 177. While the threat is pronounced within DR Congo, it remains rated as “low” on a global scale, according to WHO Director-General Dr Tedros Adhanom Ghebreyesus.
Current Situation in DR Congo
The recent outbreak involves the Bundibugyo strain of the Ebola virus, which, while less common than other variants, poses significant health risks, claiming the lives of approximately one-third of those infected. As of the latest reports, 82 cases have been confirmed in DR Congo, alongside seven fatalities directly linked to the outbreak.
Dr Tedros highlighted the broader implications for Africa, noting that the regional risk is classified as “high,” particularly as the situation evolves in neighbouring Uganda, where two confirmed cases and one death from the Bundibugyo strain have been reported. Both Ugandan cases are tied to individuals who had travelled from DR Congo.
Vaccine Development Efforts
In a positive development, researchers at Oxford University are advancing a new vaccine aimed at combating the Bundibugyo strain. Expected to enter clinical trials within the next two to three months, this vaccine employs the same technology that underpinned the AstraZeneca Covid-19 vaccine. However, the path to efficacy remains uncertain, as both animal testing and human trials are essential to determine its effectiveness.
The Serum Institute of India has already positioned itself to produce the vaccine on a large scale, pending the availability of medical-grade materials from Oxford. Additionally, another experimental vaccine targeting the Bundibugyo strain is in the works, though its testing timeline could extend to six to nine months.
Dr Vasee Moorthy, an adviser on research and development at WHO, has expressed optimism about the new vaccine, calling it “the most promising” option available. He likened it to Ervebo, a vaccine that is currently in use for the more prevalent Zaire species of Ebola.
Challenges in Containment
As the outbreak worsens, the challenges facing healthcare workers in the region are compounded by violence and insecurity. Recent incidents have seen health workers come under threat, including an alarming situation in which relatives of a patient set fire to Rwampara General Hospital after health officials refused to release a body for burial due to contamination risks.
Local politician Luc Malembe Malembe described the chaos, stating that individuals began throwing projectiles and igniting tents used for isolation. Authorities intervened, deploying police to restore order and protect medical staff, who have been placed under military guard.
These disturbances underscore the critical need for community trust during health crises. Dr Tedros emphasised that fostering confidence is essential for an effective response, particularly in a region where violence can hinder containment efforts.
The Human Impact
Fear has permeated communities across eastern DR Congo, where the rapid spread of Ebola has left residents anxious and uncertain. One taxi driver from Rwampara expressed his dread, stating, “Ebola has tortured us,” while another
